FUJIFILM Holdings Co. (OTCMKTS:FUJIY) Short Interest Up 26.5% in November

FUJIFILM Holdings Co. (OTCMKTS:FUJIY - Get Free Report) was the recipient of a large growth in short interest during the month of November. As of November 30th, there was short interest totalling 4,300 shares, a growth of 26.5% from the November 15th total of 3,400 shares. Based on an average daily volume of 423,400 shares, the short-interest ratio is currently 0.0 days.

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group upgraded FUJIFILM from a "hold" rating to a "buy" rating in a research report on Tuesday, August 20th.

FUJIFILM Trading Down 1.7 %

FUJIY stock traded down $0.20 during midday trading on Friday, reaching $11.11. The stock had a trading volume of 122,780 shares, compared to its average volume of 100,548. The firm has a market cap of $27.64 billion, a price-to-earnings ratio of 15.97, a PEG ratio of 2.42 and a beta of 0.40. FUJIFILM has a twelve month low of $9.51 and a twelve month high of $13.88. The company has a quick ratio of 0.85, a current ratio of 1.35 and a debt-to-equity ratio of 0.11. The business has a fifty day simple moving average of $11.57 and a two-hundred day simple moving average of $11.95.

FUJIFILM (OTCMKTS:FUJIY - Get Free Report) last announced its quarterly earnings data on Thursday, November 7th. The technology company reported $0.55 earnings per share for the quarter. FUJIFILM had a net margin of 7.78% and a return on equity of 7.54%. The business had revenue of $5.15 billion for the quarter. As a group, research analysts expect that FUJIFILM will post 0.68 EPS for the current fiscal year.

FUJIFILM Company Profile

FUJIFILM Holdings Corporation develops, manufactures, sells, and services imaging, healthcare, materials, and business innovation solutions worldwide. The company's Healthcare segment provides products and services, such as medical devices, biomedical contract development and manufacturing organization, pharmaceutical, regenerative medicine, and cosmetics and supplements in the areas of prevention, diagnosis, and treatment.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.